Clinical and demographic characteristics associated with postural instability in patients with schizophrenia

Akihiro Koreki, Kenichi Tsunoda, Takefumi Suzuki, Jinichi Hirano, Koichiro Watanabe, Haruo Kashima, Hiroyuki Uchida

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

As people with schizophrenia grow older, prevention of falls in this older population has become a public health priority. It is therefore critically important to identify risk factors to effectively prevent falls. For this purpose, the degree of postural sway can serve as a convenient index of risk assessment. The objective of this study was to find clinical and demographic characteristics associated with postural instability. Inpatients and outpatients with schizophrenia or related psychosis were recruited at 2 hospitals in Japan. The clinical stabilometric platform, which measured a range of the trunk motion, and extrapyramidal side effects were evaluated between 9 and 11 a.m. Four hundred two subjects were enrolled (age: mean, 55.5 [SD, 14.4] years). A univariate general linear model showed that the use of antipsychotic drugs with a chlorpromazine equivalent of 10 or greater, being overweight, and inpatient treatment setting were associated with a greater degree of the range of postural sway. Another general linear model, including a subgroup of 300 subjects who did not present any extrapyramidal side effects, not only consolidated these findings, but also revealed a great degree of postural sway in older subjects. In addition, quetiapine was found to be associated with a greater range of postural sway among atypical antipsychotics. Schizophrenia patients generally showed a greater degree of postural instability, compared with the reference data of healthy people. These findings highlight truncal instability as a risk factor of falls in patients with schizophrenia, especially when they are overweight, old, and/or receiving antipsychotics with a chlorpromazine equivalent of 10 or greater, including quetiapine.

Original languageEnglish
Pages (from-to)16-21
Number of pages6
JournalJournal of Clinical Psychopharmacology
Volume31
Issue number1
DOIs
Publication statusPublished - 2011 Feb

Fingerprint

Schizophrenia
Demography
Antipsychotic Agents
Chlorpromazine
Inpatients
Linear Models
Health Priorities
Articular Range of Motion
Psychotic Disorders
Japan
Outpatients
Public Health
Population
Quetiapine Fumarate
Therapeutics

Keywords

  • adverse effect
  • aging
  • antipsychotic
  • postural sway
  • quetiapine
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Clinical and demographic characteristics associated with postural instability in patients with schizophrenia. / Koreki, Akihiro; Tsunoda, Kenichi; Suzuki, Takefumi; Hirano, Jinichi; Watanabe, Koichiro; Kashima, Haruo; Uchida, Hiroyuki.

In: Journal of Clinical Psychopharmacology, Vol. 31, No. 1, 02.2011, p. 16-21.

Research output: Contribution to journalArticle

Koreki, Akihiro ; Tsunoda, Kenichi ; Suzuki, Takefumi ; Hirano, Jinichi ; Watanabe, Koichiro ; Kashima, Haruo ; Uchida, Hiroyuki. / Clinical and demographic characteristics associated with postural instability in patients with schizophrenia. In: Journal of Clinical Psychopharmacology. 2011 ; Vol. 31, No. 1. pp. 16-21.
@article{8641cb4e656b464c96d8d78302abb0d8,
title = "Clinical and demographic characteristics associated with postural instability in patients with schizophrenia",
abstract = "As people with schizophrenia grow older, prevention of falls in this older population has become a public health priority. It is therefore critically important to identify risk factors to effectively prevent falls. For this purpose, the degree of postural sway can serve as a convenient index of risk assessment. The objective of this study was to find clinical and demographic characteristics associated with postural instability. Inpatients and outpatients with schizophrenia or related psychosis were recruited at 2 hospitals in Japan. The clinical stabilometric platform, which measured a range of the trunk motion, and extrapyramidal side effects were evaluated between 9 and 11 a.m. Four hundred two subjects were enrolled (age: mean, 55.5 [SD, 14.4] years). A univariate general linear model showed that the use of antipsychotic drugs with a chlorpromazine equivalent of 10 or greater, being overweight, and inpatient treatment setting were associated with a greater degree of the range of postural sway. Another general linear model, including a subgroup of 300 subjects who did not present any extrapyramidal side effects, not only consolidated these findings, but also revealed a great degree of postural sway in older subjects. In addition, quetiapine was found to be associated with a greater range of postural sway among atypical antipsychotics. Schizophrenia patients generally showed a greater degree of postural instability, compared with the reference data of healthy people. These findings highlight truncal instability as a risk factor of falls in patients with schizophrenia, especially when they are overweight, old, and/or receiving antipsychotics with a chlorpromazine equivalent of 10 or greater, including quetiapine.",
keywords = "adverse effect, aging, antipsychotic, postural sway, quetiapine, schizophrenia",
author = "Akihiro Koreki and Kenichi Tsunoda and Takefumi Suzuki and Jinichi Hirano and Koichiro Watanabe and Haruo Kashima and Hiroyuki Uchida",
year = "2011",
month = "2",
doi = "10.1097/JCP.0b013e318205e192",
language = "English",
volume = "31",
pages = "16--21",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Clinical and demographic characteristics associated with postural instability in patients with schizophrenia

AU - Koreki, Akihiro

AU - Tsunoda, Kenichi

AU - Suzuki, Takefumi

AU - Hirano, Jinichi

AU - Watanabe, Koichiro

AU - Kashima, Haruo

AU - Uchida, Hiroyuki

PY - 2011/2

Y1 - 2011/2

N2 - As people with schizophrenia grow older, prevention of falls in this older population has become a public health priority. It is therefore critically important to identify risk factors to effectively prevent falls. For this purpose, the degree of postural sway can serve as a convenient index of risk assessment. The objective of this study was to find clinical and demographic characteristics associated with postural instability. Inpatients and outpatients with schizophrenia or related psychosis were recruited at 2 hospitals in Japan. The clinical stabilometric platform, which measured a range of the trunk motion, and extrapyramidal side effects were evaluated between 9 and 11 a.m. Four hundred two subjects were enrolled (age: mean, 55.5 [SD, 14.4] years). A univariate general linear model showed that the use of antipsychotic drugs with a chlorpromazine equivalent of 10 or greater, being overweight, and inpatient treatment setting were associated with a greater degree of the range of postural sway. Another general linear model, including a subgroup of 300 subjects who did not present any extrapyramidal side effects, not only consolidated these findings, but also revealed a great degree of postural sway in older subjects. In addition, quetiapine was found to be associated with a greater range of postural sway among atypical antipsychotics. Schizophrenia patients generally showed a greater degree of postural instability, compared with the reference data of healthy people. These findings highlight truncal instability as a risk factor of falls in patients with schizophrenia, especially when they are overweight, old, and/or receiving antipsychotics with a chlorpromazine equivalent of 10 or greater, including quetiapine.

AB - As people with schizophrenia grow older, prevention of falls in this older population has become a public health priority. It is therefore critically important to identify risk factors to effectively prevent falls. For this purpose, the degree of postural sway can serve as a convenient index of risk assessment. The objective of this study was to find clinical and demographic characteristics associated with postural instability. Inpatients and outpatients with schizophrenia or related psychosis were recruited at 2 hospitals in Japan. The clinical stabilometric platform, which measured a range of the trunk motion, and extrapyramidal side effects were evaluated between 9 and 11 a.m. Four hundred two subjects were enrolled (age: mean, 55.5 [SD, 14.4] years). A univariate general linear model showed that the use of antipsychotic drugs with a chlorpromazine equivalent of 10 or greater, being overweight, and inpatient treatment setting were associated with a greater degree of the range of postural sway. Another general linear model, including a subgroup of 300 subjects who did not present any extrapyramidal side effects, not only consolidated these findings, but also revealed a great degree of postural sway in older subjects. In addition, quetiapine was found to be associated with a greater range of postural sway among atypical antipsychotics. Schizophrenia patients generally showed a greater degree of postural instability, compared with the reference data of healthy people. These findings highlight truncal instability as a risk factor of falls in patients with schizophrenia, especially when they are overweight, old, and/or receiving antipsychotics with a chlorpromazine equivalent of 10 or greater, including quetiapine.

KW - adverse effect

KW - aging

KW - antipsychotic

KW - postural sway

KW - quetiapine

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=78651315766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651315766&partnerID=8YFLogxK

U2 - 10.1097/JCP.0b013e318205e192

DO - 10.1097/JCP.0b013e318205e192

M3 - Article

C2 - 21192138

AN - SCOPUS:78651315766

VL - 31

SP - 16

EP - 21

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 1

ER -